nodes	percent_of_prediction	percent_of_DWPC	metapath
Timolol—ADRB2—prostate cancer	0.201	0.537	CbGaD
Timolol—CYP2C19—prostate cancer	0.173	0.463	CbGaD
Timolol—CYP2C19—Bicalutamide—prostate cancer	0.0429	0.115	CbGbCtD
Timolol—CYP2C19—Nilutamide—prostate cancer	0.0429	0.115	CbGbCtD
Timolol—CYP2C19—Flutamide—prostate cancer	0.0356	0.095	CbGbCtD
Timolol—CYP2D6—Bicalutamide—prostate cancer	0.0326	0.0871	CbGbCtD
Timolol—ABCB1—Estramustine—prostate cancer	0.0322	0.086	CbGbCtD
Timolol—CYP2D6—Abiraterone—prostate cancer	0.027	0.0722	CbGbCtD
Timolol—ABCB1—Cabazitaxel—prostate cancer	0.0212	0.0567	CbGbCtD
Timolol—ABCB1—Estrone—prostate cancer	0.0207	0.0554	CbGbCtD
Timolol—ABCB1—Ethinyl Estradiol—prostate cancer	0.0185	0.0494	CbGbCtD
Timolol—CYP2C19—Estradiol—prostate cancer	0.0148	0.0394	CbGbCtD
Timolol—ABCB1—Conjugated Estrogens—prostate cancer	0.0136	0.0362	CbGbCtD
Timolol—CYP2C19—Prednisone—prostate cancer	0.0127	0.0339	CbGbCtD
Timolol—ABCB1—Mitoxantrone—prostate cancer	0.0123	0.0329	CbGbCtD
Timolol—ABCB1—Estradiol—prostate cancer	0.0119	0.0318	CbGbCtD
Timolol—ABCB1—Prednisone—prostate cancer	0.0102	0.0274	CbGbCtD
Timolol—ABCB1—Etoposide—prostate cancer	0.00778	0.0208	CbGbCtD
Timolol—ABCB1—Docetaxel—prostate cancer	0.00712	0.019	CbGbCtD
Timolol—ABCB1—Doxorubicin—prostate cancer	0.00531	0.0142	CbGbCtD
Timolol—CYP2D6—Doxorubicin—prostate cancer	0.005	0.0134	CbGbCtD
Timolol—Levobunolol—ADRB2—prostate cancer	0.000852	0.419	CrCbGaD
Timolol—Bupranolol—ADRB2—prostate cancer	0.000616	0.303	CrCbGaD
Timolol—Penbutolol—ADRB2—prostate cancer	0.000563	0.277	CrCbGaD
Timolol—ADRB3—prostate gland—prostate cancer	0.000497	0.265	CbGeAlD
Timolol—CYP2C19—urine—prostate cancer	0.000453	0.241	CbGeAlD
Timolol—CYP2D6—urine—prostate cancer	0.000264	0.14	CbGeAlD
Timolol—ADRB1—prostate gland—prostate cancer	0.000203	0.108	CbGeAlD
Timolol—ABCB1—prostate gland—prostate cancer	6.81e-05	0.0363	CbGeAlD
Timolol—CYP2D6—renal system—prostate cancer	6.45e-05	0.0343	CbGeAlD
Timolol—ABCB1—seminal vesicle—prostate cancer	5.76e-05	0.0307	CbGeAlD
Timolol—ABCB1—epithelium—prostate cancer	5.01e-05	0.0266	CbGeAlD
Timolol—ABCB1—renal system—prostate cancer	4.64e-05	0.0247	CbGeAlD
Timolol—ABCB1—urethra—prostate cancer	4.56e-05	0.0243	CbGeAlD
Timolol—Rhinitis—Epirubicin—prostate cancer	4.45e-05	0.000248	CcSEcCtD
Timolol—Body temperature increased—Etoposide—prostate cancer	4.45e-05	0.000248	CcSEcCtD
Timolol—Abdominal pain—Etoposide—prostate cancer	4.45e-05	0.000248	CcSEcCtD
Timolol—Conjunctivitis—Doxorubicin—prostate cancer	4.45e-05	0.000248	CcSEcCtD
Timolol—Nervous system disorder—Capecitabine—prostate cancer	4.44e-05	0.000248	CcSEcCtD
Timolol—Vertigo—Prednisone—prostate cancer	4.44e-05	0.000248	CcSEcCtD
Timolol—Syncope—Prednisone—prostate cancer	4.43e-05	0.000247	CcSEcCtD
Timolol—Skin disorder—Capecitabine—prostate cancer	4.4e-05	0.000245	CcSEcCtD
Timolol—Sweating—Doxorubicin—prostate cancer	4.39e-05	0.000245	CcSEcCtD
Timolol—Hyperhidrosis—Capecitabine—prostate cancer	4.38e-05	0.000244	CcSEcCtD
Timolol—Oedema peripheral—Epirubicin—prostate cancer	4.37e-05	0.000244	CcSEcCtD
Timolol—Hypotension—Docetaxel—prostate cancer	4.37e-05	0.000244	CcSEcCtD
Timolol—Connective tissue disorder—Epirubicin—prostate cancer	4.36e-05	0.000243	CcSEcCtD
Timolol—Loss of consciousness—Prednisone—prostate cancer	4.34e-05	0.000242	CcSEcCtD
Timolol—Epistaxis—Doxorubicin—prostate cancer	4.32e-05	0.000241	CcSEcCtD
Timolol—Anorexia—Capecitabine—prostate cancer	4.32e-05	0.000241	CcSEcCtD
Timolol—Nausea—Estradiol—prostate cancer	4.31e-05	0.00024	CcSEcCtD
Timolol—Vomiting—Mitoxantrone—prostate cancer	4.3e-05	0.00024	CcSEcCtD
Timolol—Sinusitis—Doxorubicin—prostate cancer	4.29e-05	0.000239	CcSEcCtD
Timolol—Visual impairment—Epirubicin—prostate cancer	4.28e-05	0.000239	CcSEcCtD
Timolol—Agranulocytosis—Doxorubicin—prostate cancer	4.27e-05	0.000238	CcSEcCtD
Timolol—Hypertension—Prednisone—prostate cancer	4.27e-05	0.000238	CcSEcCtD
Timolol—Rash—Mitoxantrone—prostate cancer	4.27e-05	0.000238	CcSEcCtD
Timolol—Dermatitis—Mitoxantrone—prostate cancer	4.26e-05	0.000238	CcSEcCtD
Timolol—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.26e-05	0.000238	CcSEcCtD
Timolol—Headache—Mitoxantrone—prostate cancer	4.24e-05	0.000236	CcSEcCtD
Timolol—Hypotension—Capecitabine—prostate cancer	4.23e-05	0.000236	CcSEcCtD
Timolol—Insomnia—Docetaxel—prostate cancer	4.23e-05	0.000236	CcSEcCtD
Timolol—Myalgia—Prednisone—prostate cancer	4.21e-05	0.000235	CcSEcCtD
Timolol—Arthralgia—Prednisone—prostate cancer	4.21e-05	0.000235	CcSEcCtD
Timolol—Paraesthesia—Docetaxel—prostate cancer	4.2e-05	0.000234	CcSEcCtD
Timolol—Anxiety—Prednisone—prostate cancer	4.19e-05	0.000234	CcSEcCtD
Timolol—Bradycardia—Doxorubicin—prostate cancer	4.18e-05	0.000233	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.18e-05	0.000233	CcSEcCtD
Timolol—CYP2D6—testis—prostate cancer	4.17e-05	0.0222	CbGeAlD
Timolol—Dyspnoea—Docetaxel—prostate cancer	4.17e-05	0.000232	CcSEcCtD
Timolol—Somnolence—Docetaxel—prostate cancer	4.16e-05	0.000232	CcSEcCtD
Timolol—Discomfort—Prednisone—prostate cancer	4.16e-05	0.000232	CcSEcCtD
Timolol—Eye disorder—Epirubicin—prostate cancer	4.15e-05	0.000231	CcSEcCtD
Timolol—Hypersensitivity—Etoposide—prostate cancer	4.15e-05	0.000231	CcSEcCtD
Timolol—Tinnitus—Epirubicin—prostate cancer	4.14e-05	0.000231	CcSEcCtD
Timolol—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.13e-05	0.00023	CcSEcCtD
Timolol—Cardiac disorder—Epirubicin—prostate cancer	4.12e-05	0.00023	CcSEcCtD
Timolol—Rhinitis—Doxorubicin—prostate cancer	4.12e-05	0.00023	CcSEcCtD
Timolol—Dyspepsia—Docetaxel—prostate cancer	4.12e-05	0.00023	CcSEcCtD
Timolol—Insomnia—Capecitabine—prostate cancer	4.1e-05	0.000228	CcSEcCtD
Timolol—Paraesthesia—Capecitabine—prostate cancer	4.07e-05	0.000227	CcSEcCtD
Timolol—Decreased appetite—Docetaxel—prostate cancer	4.07e-05	0.000227	CcSEcCtD
Timolol—Oedema peripheral—Doxorubicin—prostate cancer	4.05e-05	0.000226	CcSEcCtD
Timolol—Gastrointestinal disorder—Docetaxel—prostate cancer	4.04e-05	0.000225	CcSEcCtD
Timolol—Asthenia—Etoposide—prostate cancer	4.04e-05	0.000225	CcSEcCtD
Timolol—Connective tissue disorder—Doxorubicin—prostate cancer	4.04e-05	0.000225	CcSEcCtD
Timolol—Dyspnoea—Capecitabine—prostate cancer	4.04e-05	0.000225	CcSEcCtD
Timolol—Oedema—Prednisone—prostate cancer	4.03e-05	0.000225	CcSEcCtD
Timolol—Anaphylactic shock—Prednisone—prostate cancer	4.03e-05	0.000225	CcSEcCtD
Timolol—Fatigue—Docetaxel—prostate cancer	4.03e-05	0.000225	CcSEcCtD
Timolol—Angiopathy—Epirubicin—prostate cancer	4.03e-05	0.000225	CcSEcCtD
Timolol—Nausea—Mitoxantrone—prostate cancer	4.02e-05	0.000224	CcSEcCtD
Timolol—Immune system disorder—Epirubicin—prostate cancer	4.01e-05	0.000224	CcSEcCtD
Timolol—Infection—Prednisone—prostate cancer	4.01e-05	0.000223	CcSEcCtD
Timolol—Mediastinal disorder—Epirubicin—prostate cancer	4e-05	0.000223	CcSEcCtD
Timolol—Pain—Docetaxel—prostate cancer	4e-05	0.000223	CcSEcCtD
Timolol—Dyspepsia—Capecitabine—prostate cancer	3.99e-05	0.000222	CcSEcCtD
Timolol—Pruritus—Etoposide—prostate cancer	3.98e-05	0.000222	CcSEcCtD
Timolol—Shock—Prednisone—prostate cancer	3.97e-05	0.000221	CcSEcCtD
Timolol—Arrhythmia—Epirubicin—prostate cancer	3.97e-05	0.000221	CcSEcCtD
Timolol—Visual impairment—Doxorubicin—prostate cancer	3.96e-05	0.000221	CcSEcCtD
Timolol—Nervous system disorder—Prednisone—prostate cancer	3.96e-05	0.000221	CcSEcCtD
Timolol—Decreased appetite—Capecitabine—prostate cancer	3.94e-05	0.000219	CcSEcCtD
Timolol—Alopecia—Epirubicin—prostate cancer	3.92e-05	0.000219	CcSEcCtD
Timolol—Skin disorder—Prednisone—prostate cancer	3.92e-05	0.000218	CcSEcCtD
Timolol—Gastrointestinal disorder—Capecitabine—prostate cancer	3.91e-05	0.000218	CcSEcCtD
Timolol—Fatigue—Capecitabine—prostate cancer	3.9e-05	0.000218	CcSEcCtD
Timolol—Hyperhidrosis—Prednisone—prostate cancer	3.9e-05	0.000217	CcSEcCtD
Timolol—Mental disorder—Epirubicin—prostate cancer	3.89e-05	0.000217	CcSEcCtD
Timolol—Pain—Capecitabine—prostate cancer	3.87e-05	0.000216	CcSEcCtD
Timolol—Erythema—Epirubicin—prostate cancer	3.86e-05	0.000216	CcSEcCtD
Timolol—Malnutrition—Epirubicin—prostate cancer	3.86e-05	0.000216	CcSEcCtD
Timolol—Feeling abnormal—Docetaxel—prostate cancer	3.85e-05	0.000215	CcSEcCtD
Timolol—Diarrhoea—Etoposide—prostate cancer	3.85e-05	0.000215	CcSEcCtD
Timolol—Anorexia—Prednisone—prostate cancer	3.84e-05	0.000214	CcSEcCtD
Timolol—Eye disorder—Doxorubicin—prostate cancer	3.84e-05	0.000214	CcSEcCtD
Timolol—Tinnitus—Doxorubicin—prostate cancer	3.83e-05	0.000214	CcSEcCtD
Timolol—Gastrointestinal pain—Docetaxel—prostate cancer	3.82e-05	0.000213	CcSEcCtD
Timolol—Cardiac disorder—Doxorubicin—prostate cancer	3.81e-05	0.000213	CcSEcCtD
Timolol—Tension—Epirubicin—prostate cancer	3.79e-05	0.000211	CcSEcCtD
Timolol—Dysgeusia—Epirubicin—prostate cancer	3.78e-05	0.000211	CcSEcCtD
Timolol—Nervousness—Epirubicin—prostate cancer	3.75e-05	0.000209	CcSEcCtD
Timolol—Feeling abnormal—Capecitabine—prostate cancer	3.73e-05	0.000208	CcSEcCtD
Timolol—Angiopathy—Doxorubicin—prostate cancer	3.73e-05	0.000208	CcSEcCtD
Timolol—Dizziness—Etoposide—prostate cancer	3.72e-05	0.000208	CcSEcCtD
Timolol—Immune system disorder—Doxorubicin—prostate cancer	3.71e-05	0.000207	CcSEcCtD
Timolol—Gastrointestinal pain—Capecitabine—prostate cancer	3.7e-05	0.000206	CcSEcCtD
Timolol—Mediastinal disorder—Doxorubicin—prostate cancer	3.7e-05	0.000206	CcSEcCtD
Timolol—Abdominal pain—Docetaxel—prostate cancer	3.7e-05	0.000206	CcSEcCtD
Timolol—Body temperature increased—Docetaxel—prostate cancer	3.7e-05	0.000206	CcSEcCtD
Timolol—Musculoskeletal discomfort—Prednisone—prostate cancer	3.67e-05	0.000205	CcSEcCtD
Timolol—Arrhythmia—Doxorubicin—prostate cancer	3.67e-05	0.000205	CcSEcCtD
Timolol—Insomnia—Prednisone—prostate cancer	3.65e-05	0.000203	CcSEcCtD
Timolol—Vision blurred—Epirubicin—prostate cancer	3.64e-05	0.000203	CcSEcCtD
Timolol—Alopecia—Doxorubicin—prostate cancer	3.63e-05	0.000202	CcSEcCtD
Timolol—Paraesthesia—Prednisone—prostate cancer	3.62e-05	0.000202	CcSEcCtD
Timolol—Mental disorder—Doxorubicin—prostate cancer	3.6e-05	0.000201	CcSEcCtD
Timolol—Urticaria—Capecitabine—prostate cancer	3.6e-05	0.000201	CcSEcCtD
Timolol—Body temperature increased—Capecitabine—prostate cancer	3.58e-05	0.0002	CcSEcCtD
Timolol—Abdominal pain—Capecitabine—prostate cancer	3.58e-05	0.0002	CcSEcCtD
Timolol—Vomiting—Etoposide—prostate cancer	3.58e-05	0.0002	CcSEcCtD
Timolol—Erythema—Doxorubicin—prostate cancer	3.58e-05	0.000199	CcSEcCtD
Timolol—Malnutrition—Doxorubicin—prostate cancer	3.58e-05	0.000199	CcSEcCtD
Timolol—Dyspepsia—Prednisone—prostate cancer	3.55e-05	0.000198	CcSEcCtD
Timolol—Rash—Etoposide—prostate cancer	3.55e-05	0.000198	CcSEcCtD
Timolol—Dermatitis—Etoposide—prostate cancer	3.54e-05	0.000198	CcSEcCtD
Timolol—Headache—Etoposide—prostate cancer	3.53e-05	0.000197	CcSEcCtD
Timolol—ABCB1—bone marrow—prostate cancer	3.51e-05	0.0187	CbGeAlD
Timolol—Tension—Doxorubicin—prostate cancer	3.51e-05	0.000196	CcSEcCtD
Timolol—Decreased appetite—Prednisone—prostate cancer	3.51e-05	0.000196	CcSEcCtD
Timolol—Dysgeusia—Doxorubicin—prostate cancer	3.5e-05	0.000195	CcSEcCtD
Timolol—Fatigue—Prednisone—prostate cancer	3.48e-05	0.000194	CcSEcCtD
Timolol—Nervousness—Doxorubicin—prostate cancer	3.47e-05	0.000194	CcSEcCtD
Timolol—Vertigo—Epirubicin—prostate cancer	3.47e-05	0.000194	CcSEcCtD
Timolol—Syncope—Epirubicin—prostate cancer	3.47e-05	0.000193	CcSEcCtD
Timolol—Hypersensitivity—Docetaxel—prostate cancer	3.45e-05	0.000192	CcSEcCtD
Timolol—Palpitations—Epirubicin—prostate cancer	3.42e-05	0.00019	CcSEcCtD
Timolol—Loss of consciousness—Epirubicin—prostate cancer	3.4e-05	0.000189	CcSEcCtD
Timolol—Cough—Epirubicin—prostate cancer	3.37e-05	0.000188	CcSEcCtD
Timolol—Vision blurred—Doxorubicin—prostate cancer	3.37e-05	0.000188	CcSEcCtD
Timolol—Asthenia—Docetaxel—prostate cancer	3.36e-05	0.000187	CcSEcCtD
Timolol—Nausea—Etoposide—prostate cancer	3.34e-05	0.000186	CcSEcCtD
Timolol—Hypertension—Epirubicin—prostate cancer	3.34e-05	0.000186	CcSEcCtD
Timolol—Hypersensitivity—Capecitabine—prostate cancer	3.34e-05	0.000186	CcSEcCtD
Timolol—Feeling abnormal—Prednisone—prostate cancer	3.32e-05	0.000185	CcSEcCtD
Timolol—Pruritus—Docetaxel—prostate cancer	3.31e-05	0.000185	CcSEcCtD
Timolol—Gastrointestinal pain—Prednisone—prostate cancer	3.3e-05	0.000184	CcSEcCtD
Timolol—Arthralgia—Epirubicin—prostate cancer	3.29e-05	0.000183	CcSEcCtD
Timolol—Myalgia—Epirubicin—prostate cancer	3.29e-05	0.000183	CcSEcCtD
Timolol—Chest pain—Epirubicin—prostate cancer	3.29e-05	0.000183	CcSEcCtD
Timolol—Anxiety—Epirubicin—prostate cancer	3.28e-05	0.000183	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.27e-05	0.000182	CcSEcCtD
Timolol—Discomfort—Epirubicin—prostate cancer	3.25e-05	0.000181	CcSEcCtD
Timolol—Asthenia—Capecitabine—prostate cancer	3.25e-05	0.000181	CcSEcCtD
Timolol—Dry mouth—Epirubicin—prostate cancer	3.22e-05	0.000179	CcSEcCtD
Timolol—Vertigo—Doxorubicin—prostate cancer	3.21e-05	0.000179	CcSEcCtD
Timolol—Syncope—Doxorubicin—prostate cancer	3.21e-05	0.000179	CcSEcCtD
Timolol—Urticaria—Prednisone—prostate cancer	3.2e-05	0.000179	CcSEcCtD
Timolol—Pruritus—Capecitabine—prostate cancer	3.2e-05	0.000179	CcSEcCtD
Timolol—Diarrhoea—Docetaxel—prostate cancer	3.2e-05	0.000178	CcSEcCtD
Timolol—Body temperature increased—Prednisone—prostate cancer	3.19e-05	0.000178	CcSEcCtD
Timolol—Abdominal pain—Prednisone—prostate cancer	3.19e-05	0.000178	CcSEcCtD
Timolol—Confusional state—Epirubicin—prostate cancer	3.18e-05	0.000177	CcSEcCtD
Timolol—Palpitations—Doxorubicin—prostate cancer	3.16e-05	0.000176	CcSEcCtD
Timolol—Oedema—Epirubicin—prostate cancer	3.15e-05	0.000176	CcSEcCtD
Timolol—Anaphylactic shock—Epirubicin—prostate cancer	3.15e-05	0.000176	CcSEcCtD
Timolol—Loss of consciousness—Doxorubicin—prostate cancer	3.14e-05	0.000175	CcSEcCtD
Timolol—Infection—Epirubicin—prostate cancer	3.13e-05	0.000175	CcSEcCtD
Timolol—Cough—Doxorubicin—prostate cancer	3.12e-05	0.000174	CcSEcCtD
Timolol—Shock—Epirubicin—prostate cancer	3.1e-05	0.000173	CcSEcCtD
Timolol—Diarrhoea—Capecitabine—prostate cancer	3.1e-05	0.000173	CcSEcCtD
Timolol—Nervous system disorder—Epirubicin—prostate cancer	3.09e-05	0.000173	CcSEcCtD
Timolol—Dizziness—Docetaxel—prostate cancer	3.09e-05	0.000172	CcSEcCtD
Timolol—Hypertension—Doxorubicin—prostate cancer	3.09e-05	0.000172	CcSEcCtD
Timolol—Skin disorder—Epirubicin—prostate cancer	3.06e-05	0.000171	CcSEcCtD
Timolol—Hyperhidrosis—Epirubicin—prostate cancer	3.05e-05	0.00017	CcSEcCtD
Timolol—Chest pain—Doxorubicin—prostate cancer	3.04e-05	0.00017	CcSEcCtD
Timolol—Myalgia—Doxorubicin—prostate cancer	3.04e-05	0.00017	CcSEcCtD
Timolol—Arthralgia—Doxorubicin—prostate cancer	3.04e-05	0.00017	CcSEcCtD
Timolol—Anxiety—Doxorubicin—prostate cancer	3.03e-05	0.000169	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.02e-05	0.000169	CcSEcCtD
Timolol—Discomfort—Doxorubicin—prostate cancer	3.01e-05	0.000168	CcSEcCtD
Timolol—Anorexia—Epirubicin—prostate cancer	3.01e-05	0.000168	CcSEcCtD
Timolol—ABCB1—testis—prostate cancer	3e-05	0.016	CbGeAlD
Timolol—Dizziness—Capecitabine—prostate cancer	2.99e-05	0.000167	CcSEcCtD
Timolol—Dry mouth—Doxorubicin—prostate cancer	2.98e-05	0.000166	CcSEcCtD
Timolol—Vomiting—Docetaxel—prostate cancer	2.97e-05	0.000166	CcSEcCtD
Timolol—Hypersensitivity—Prednisone—prostate cancer	2.97e-05	0.000166	CcSEcCtD
Timolol—Rash—Docetaxel—prostate cancer	2.95e-05	0.000164	CcSEcCtD
Timolol—Hypotension—Epirubicin—prostate cancer	2.95e-05	0.000164	CcSEcCtD
Timolol—Dermatitis—Docetaxel—prostate cancer	2.95e-05	0.000164	CcSEcCtD
Timolol—Confusional state—Doxorubicin—prostate cancer	2.94e-05	0.000164	CcSEcCtD
Timolol—Headache—Docetaxel—prostate cancer	2.93e-05	0.000163	CcSEcCtD
Timolol—Anaphylactic shock—Doxorubicin—prostate cancer	2.92e-05	0.000163	CcSEcCtD
Timolol—Oedema—Doxorubicin—prostate cancer	2.92e-05	0.000163	CcSEcCtD
Timolol—Infection—Doxorubicin—prostate cancer	2.9e-05	0.000162	CcSEcCtD
Timolol—Asthenia—Prednisone—prostate cancer	2.89e-05	0.000161	CcSEcCtD
Timolol—Vomiting—Capecitabine—prostate cancer	2.88e-05	0.000161	CcSEcCtD
Timolol—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.87e-05	0.00016	CcSEcCtD
Timolol—Shock—Doxorubicin—prostate cancer	2.87e-05	0.00016	CcSEcCtD
Timolol—Nervous system disorder—Doxorubicin—prostate cancer	2.86e-05	0.00016	CcSEcCtD
Timolol—Rash—Capecitabine—prostate cancer	2.85e-05	0.000159	CcSEcCtD
Timolol—Pruritus—Prednisone—prostate cancer	2.85e-05	0.000159	CcSEcCtD
Timolol—Insomnia—Epirubicin—prostate cancer	2.85e-05	0.000159	CcSEcCtD
Timolol—Dermatitis—Capecitabine—prostate cancer	2.85e-05	0.000159	CcSEcCtD
Timolol—Headache—Capecitabine—prostate cancer	2.84e-05	0.000158	CcSEcCtD
Timolol—Skin disorder—Doxorubicin—prostate cancer	2.83e-05	0.000158	CcSEcCtD
Timolol—Paraesthesia—Epirubicin—prostate cancer	2.83e-05	0.000158	CcSEcCtD
Timolol—Hyperhidrosis—Doxorubicin—prostate cancer	2.82e-05	0.000157	CcSEcCtD
Timolol—Dyspnoea—Epirubicin—prostate cancer	2.81e-05	0.000157	CcSEcCtD
Timolol—Somnolence—Epirubicin—prostate cancer	2.8e-05	0.000156	CcSEcCtD
Timolol—Anorexia—Doxorubicin—prostate cancer	2.78e-05	0.000155	CcSEcCtD
Timolol—Nausea—Docetaxel—prostate cancer	2.78e-05	0.000155	CcSEcCtD
Timolol—Dyspepsia—Epirubicin—prostate cancer	2.78e-05	0.000155	CcSEcCtD
Timolol—Diarrhoea—Prednisone—prostate cancer	2.76e-05	0.000154	CcSEcCtD
Timolol—Decreased appetite—Epirubicin—prostate cancer	2.74e-05	0.000153	CcSEcCtD
Timolol—Hypotension—Doxorubicin—prostate cancer	2.73e-05	0.000152	CcSEcCtD
Timolol—Gastrointestinal disorder—Epirubicin—prostate cancer	2.72e-05	0.000152	CcSEcCtD
Timolol—Fatigue—Epirubicin—prostate cancer	2.72e-05	0.000152	CcSEcCtD
Timolol—Pain—Epirubicin—prostate cancer	2.7e-05	0.00015	CcSEcCtD
Timolol—Nausea—Capecitabine—prostate cancer	2.69e-05	0.00015	CcSEcCtD
Timolol—Dizziness—Prednisone—prostate cancer	2.67e-05	0.000149	CcSEcCtD
Timolol—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.66e-05	0.000148	CcSEcCtD
Timolol—Insomnia—Doxorubicin—prostate cancer	2.64e-05	0.000147	CcSEcCtD
Timolol—Paraesthesia—Doxorubicin—prostate cancer	2.62e-05	0.000146	CcSEcCtD
Timolol—Dyspnoea—Doxorubicin—prostate cancer	2.6e-05	0.000145	CcSEcCtD
Timolol—Feeling abnormal—Epirubicin—prostate cancer	2.6e-05	0.000145	CcSEcCtD
Timolol—Somnolence—Doxorubicin—prostate cancer	2.59e-05	0.000145	CcSEcCtD
Timolol—Gastrointestinal pain—Epirubicin—prostate cancer	2.58e-05	0.000144	CcSEcCtD
Timolol—Dyspepsia—Doxorubicin—prostate cancer	2.57e-05	0.000143	CcSEcCtD
Timolol—Vomiting—Prednisone—prostate cancer	2.56e-05	0.000143	CcSEcCtD
Timolol—Rash—Prednisone—prostate cancer	2.54e-05	0.000142	CcSEcCtD
Timolol—Dermatitis—Prednisone—prostate cancer	2.54e-05	0.000142	CcSEcCtD
Timolol—Decreased appetite—Doxorubicin—prostate cancer	2.54e-05	0.000141	CcSEcCtD
Timolol—Headache—Prednisone—prostate cancer	2.53e-05	0.000141	CcSEcCtD
Timolol—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.52e-05	0.000141	CcSEcCtD
Timolol—Fatigue—Doxorubicin—prostate cancer	2.52e-05	0.00014	CcSEcCtD
Timolol—Urticaria—Epirubicin—prostate cancer	2.51e-05	0.00014	CcSEcCtD
Timolol—Pain—Doxorubicin—prostate cancer	2.5e-05	0.000139	CcSEcCtD
Timolol—Body temperature increased—Epirubicin—prostate cancer	2.49e-05	0.000139	CcSEcCtD
Timolol—Abdominal pain—Epirubicin—prostate cancer	2.49e-05	0.000139	CcSEcCtD
Timolol—Feeling abnormal—Doxorubicin—prostate cancer	2.41e-05	0.000134	CcSEcCtD
Timolol—Nausea—Prednisone—prostate cancer	2.4e-05	0.000134	CcSEcCtD
Timolol—Gastrointestinal pain—Doxorubicin—prostate cancer	2.39e-05	0.000133	CcSEcCtD
Timolol—Hypersensitivity—Epirubicin—prostate cancer	2.32e-05	0.00013	CcSEcCtD
Timolol—Urticaria—Doxorubicin—prostate cancer	2.32e-05	0.000129	CcSEcCtD
Timolol—Body temperature increased—Doxorubicin—prostate cancer	2.31e-05	0.000129	CcSEcCtD
Timolol—Abdominal pain—Doxorubicin—prostate cancer	2.31e-05	0.000129	CcSEcCtD
Timolol—Asthenia—Epirubicin—prostate cancer	2.26e-05	0.000126	CcSEcCtD
Timolol—Pruritus—Epirubicin—prostate cancer	2.23e-05	0.000124	CcSEcCtD
Timolol—ABCB1—lymph node—prostate cancer	2.18e-05	0.0116	CbGeAlD
Timolol—Diarrhoea—Epirubicin—prostate cancer	2.16e-05	0.00012	CcSEcCtD
Timolol—Hypersensitivity—Doxorubicin—prostate cancer	2.15e-05	0.00012	CcSEcCtD
Timolol—Asthenia—Doxorubicin—prostate cancer	2.09e-05	0.000117	CcSEcCtD
Timolol—Dizziness—Epirubicin—prostate cancer	2.09e-05	0.000116	CcSEcCtD
Timolol—Pruritus—Doxorubicin—prostate cancer	2.06e-05	0.000115	CcSEcCtD
Timolol—Vomiting—Epirubicin—prostate cancer	2.01e-05	0.000112	CcSEcCtD
Timolol—Diarrhoea—Doxorubicin—prostate cancer	2e-05	0.000111	CcSEcCtD
Timolol—Rash—Epirubicin—prostate cancer	1.99e-05	0.000111	CcSEcCtD
Timolol—Dermatitis—Epirubicin—prostate cancer	1.99e-05	0.000111	CcSEcCtD
Timolol—Headache—Epirubicin—prostate cancer	1.98e-05	0.00011	CcSEcCtD
Timolol—Dizziness—Doxorubicin—prostate cancer	1.93e-05	0.000108	CcSEcCtD
Timolol—Nausea—Epirubicin—prostate cancer	1.87e-05	0.000104	CcSEcCtD
Timolol—Vomiting—Doxorubicin—prostate cancer	1.86e-05	0.000103	CcSEcCtD
Timolol—Rash—Doxorubicin—prostate cancer	1.84e-05	0.000103	CcSEcCtD
Timolol—Dermatitis—Doxorubicin—prostate cancer	1.84e-05	0.000103	CcSEcCtD
Timolol—Headache—Doxorubicin—prostate cancer	1.83e-05	0.000102	CcSEcCtD
Timolol—Nausea—Doxorubicin—prostate cancer	1.73e-05	9.67e-05	CcSEcCtD
Timolol—ABCB1—Metabolism—PRKACB—prostate cancer	5.96e-06	8.72e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ITGB3—prostate cancer	5.92e-06	8.66e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—CXCL8—prostate cancer	5.91e-06	8.64e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP17A1—prostate cancer	5.9e-06	8.63e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CXCL8—prostate cancer	5.88e-06	8.6e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTT1—prostate cancer	5.87e-06	8.59e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ACHE—prostate cancer	5.87e-06	8.59e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ERBB3—prostate cancer	5.87e-06	8.59e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FGFR2—prostate cancer	5.86e-06	8.57e-05	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.83e-06	8.53e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP2A6—prostate cancer	5.8e-06	8.49e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—CXCL8—prostate cancer	5.78e-06	8.46e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NCOA2—prostate cancer	5.76e-06	8.42e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CDKN1B—prostate cancer	5.74e-06	8.4e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ERBB3—prostate cancer	5.74e-06	8.4e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FGFR2—prostate cancer	5.73e-06	8.39e-05	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—AKT1—prostate cancer	5.68e-06	8.31e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—IL2—prostate cancer	5.65e-06	8.26e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—AKR1C3—prostate cancer	5.65e-06	8.26e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CASP3—prostate cancer	5.63e-06	8.23e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TERT—prostate cancer	5.63e-06	8.23e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NCOA2—prostate cancer	5.62e-06	8.22e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IL2—prostate cancer	5.62e-06	8.22e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PRKACB—prostate cancer	5.62e-06	8.22e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—IL6—prostate cancer	5.59e-06	8.18e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP17A1—prostate cancer	5.56e-06	8.13e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL2—prostate cancer	5.52e-06	8.08e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TERT—prostate cancer	5.5e-06	8.05e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SLC5A5—prostate cancer	5.49e-06	8.04e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CCND1—prostate cancer	5.48e-06	8.01e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CTNNB1—prostate cancer	5.43e-06	7.94e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HIF1A—prostate cancer	5.38e-06	7.87e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP2E1—prostate cancer	5.37e-06	7.85e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SLC5A5—prostate cancer	5.36e-06	7.84e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MMP9—prostate cancer	5.32e-06	7.78e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NQO1—prostate cancer	5.31e-06	7.76e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CDKN1A—prostate cancer	5.3e-06	7.75e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NCOA2—prostate cancer	5.3e-06	7.75e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PTEN—prostate cancer	5.29e-06	7.74e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HIF1A—prostate cancer	5.26e-06	7.7e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—LEP—prostate cancer	5.25e-06	7.68e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP2E1—prostate cancer	5.24e-06	7.66e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—TH—prostate cancer	5.23e-06	7.65e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CAV1—prostate cancer	5.2e-06	7.61e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.2e-06	7.6e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NQO1—prostate cancer	5.18e-06	7.58e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP3A4—prostate cancer	5.17e-06	7.57e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—AKT1—prostate cancer	5.16e-06	7.55e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.15e-06	7.53e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KDR—prostate cancer	5.15e-06	7.53e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—LEP—prostate cancer	5.14e-06	7.52e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—TH—prostate cancer	5.1e-06	7.47e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CAV1—prostate cancer	5.09e-06	7.45e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP1B1—prostate cancer	5.09e-06	7.44e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SLC5A5—prostate cancer	5.05e-06	7.39e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP3A4—prostate cancer	5.05e-06	7.39e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—EP300—prostate cancer	5.04e-06	7.38e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KDR—prostate cancer	5.03e-06	7.36e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ESR1—prostate cancer	5.01e-06	7.34e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP1B1—prostate cancer	4.96e-06	7.26e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP2E1—prostate cancer	4.93e-06	7.22e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GGT1—prostate cancer	4.93e-06	7.21e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ESR1—prostate cancer	4.91e-06	7.18e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—SRC—prostate cancer	4.9e-06	7.17e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—BAD—prostate cancer	4.89e-06	7.16e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NQO1—prostate cancer	4.88e-06	7.14e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NCOA1—prostate cancer	4.85e-06	7.1e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—TH—prostate cancer	4.81e-06	7.04e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GGT1—prostate cancer	4.81e-06	7.03e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—BAD—prostate cancer	4.79e-06	7e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP19A1—prostate cancer	4.78e-06	7e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—VEGFA—prostate cancer	4.78e-06	6.99e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP3A4—prostate cancer	4.76e-06	6.96e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CG—prostate cancer	4.74e-06	6.93e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—APC—prostate cancer	4.74e-06	6.93e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NCOA1—prostate cancer	4.74e-06	6.93e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—STAT3—prostate cancer	4.73e-06	6.92e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IRS1—prostate cancer	4.69e-06	6.85e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EGF—prostate cancer	4.69e-06	6.85e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP1B1—prostate cancer	4.68e-06	6.84e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP19A1—prostate cancer	4.67e-06	6.83e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CG—prostate cancer	4.64e-06	6.78e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—APC—prostate cancer	4.64e-06	6.78e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—RXRA—prostate cancer	4.62e-06	6.75e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IRS1—prostate cancer	4.58e-06	6.71e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EGF—prostate cancer	4.58e-06	6.71e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—GSK3B—prostate cancer	4.55e-06	6.65e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GGT1—prostate cancer	4.53e-06	6.63e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—RXRA—prostate cancer	4.5e-06	6.59e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.49e-06	6.57e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—INS—prostate cancer	4.49e-06	6.56e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NCOA1—prostate cancer	4.46e-06	6.53e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—GSK3B—prostate cancer	4.45e-06	6.51e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—COMT—prostate cancer	4.45e-06	6.5e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTP1—prostate cancer	4.42e-06	6.47e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP19A1—prostate cancer	4.4e-06	6.43e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CREBBP—prostate cancer	4.39e-06	6.43e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MYC—prostate cancer	4.39e-06	6.43e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—INS—prostate cancer	4.39e-06	6.42e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TGFB1—prostate cancer	4.38e-06	6.41e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ITPR1—prostate cancer	4.35e-06	6.37e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IGF1—prostate cancer	4.34e-06	6.35e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—COMT—prostate cancer	4.34e-06	6.35e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTP1—prostate cancer	4.32e-06	6.32e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—EGFR—prostate cancer	4.32e-06	6.32e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CREBBP—prostate cancer	4.3e-06	6.29e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—EGFR—prostate cancer	4.3e-06	6.29e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.28e-06	6.26e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ITPR1—prostate cancer	4.25e-06	6.22e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IGF1—prostate cancer	4.25e-06	6.21e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—RXRA—prostate cancer	4.25e-06	6.21e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—EGFR—prostate cancer	4.22e-06	6.18e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MAP2K1—prostate cancer	4.19e-06	6.14e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CD—prostate cancer	4.17e-06	6.1e-05	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PIK3CA—prostate cancer	4.13e-06	6.04e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SERPINE1—prostate cancer	4.12e-06	6.03e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—TYMS—prostate cancer	4.11e-06	6.02e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MAP2K1—prostate cancer	4.1e-06	6e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—COMT—prostate cancer	4.09e-06	5.98e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—KRAS—prostate cancer	4.08e-06	5.97e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CD—prostate cancer	4.08e-06	5.96e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTP1—prostate cancer	4.07e-06	5.95e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTM1—prostate cancer	4.07e-06	5.95e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—KRAS—prostate cancer	4.06e-06	5.94e-05	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PIK3CA—prostate cancer	4.04e-06	5.91e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SERPINE1—prostate cancer	4.03e-06	5.9e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—TYMS—prostate cancer	4.02e-06	5.87e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ITPR1—prostate cancer	4e-06	5.86e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—LPL—prostate cancer	3.99e-06	5.84e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—KRAS—prostate cancer	3.99e-06	5.84e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FGF2—prostate cancer	3.99e-06	5.84e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTM1—prostate cancer	3.97e-06	5.81e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NOS3—prostate cancer	3.93e-06	5.76e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FGF2—prostate cancer	3.9e-06	5.71e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—LPL—prostate cancer	3.9e-06	5.7e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP1A1—prostate cancer	3.85e-06	5.64e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NOS3—prostate cancer	3.85e-06	5.63e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—JAK2—prostate cancer	3.82e-06	5.59e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ERCC2—prostate cancer	3.82e-06	5.59e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—TYMS—prostate cancer	3.78e-06	5.54e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP1A1—prostate cancer	3.76e-06	5.5e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CA—prostate cancer	3.75e-06	5.48e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—JAK2—prostate cancer	3.74e-06	5.47e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTM1—prostate cancer	3.74e-06	5.47e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MDM2—prostate cancer	3.73e-06	5.46e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ERCC2—prostate cancer	3.73e-06	5.46e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CA—prostate cancer	3.73e-06	5.46e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ERBB2—prostate cancer	3.68e-06	5.38e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—LPL—prostate cancer	3.67e-06	5.37e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CA—prostate cancer	3.67e-06	5.36e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MDM2—prostate cancer	3.65e-06	5.34e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CB—prostate cancer	3.63e-06	5.31e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TP53—prostate cancer	3.61e-06	5.28e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ERBB2—prostate cancer	3.6e-06	5.27e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—MTHFR—prostate cancer	3.59e-06	5.26e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CB—prostate cancer	3.55e-06	5.2e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.55e-06	5.19e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PPARA—prostate cancer	3.53e-06	5.16e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ERCC2—prostate cancer	3.52e-06	5.14e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—MTHFR—prostate cancer	3.51e-06	5.13e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CXCL8—prostate cancer	3.49e-06	5.11e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PPARA—prostate cancer	3.44e-06	5.03e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CXCL8—prostate cancer	3.41e-06	4.99e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CDKN1B—prostate cancer	3.41e-06	4.99e-05	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—AKT1—prostate cancer	3.37e-06	4.93e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CASP3—prostate cancer	3.34e-06	4.89e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL2—prostate cancer	3.34e-06	4.88e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CDKN1B—prostate cancer	3.33e-06	4.88e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—IL6—prostate cancer	3.32e-06	4.86e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CAV1—prostate cancer	3.31e-06	4.85e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—MTHFR—prostate cancer	3.31e-06	4.84e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IL6—prostate cancer	3.3e-06	4.83e-05	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—AKT1—prostate cancer	3.3e-06	4.83e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CASP3—prostate cancer	3.27e-06	4.78e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL2—prostate cancer	3.26e-06	4.77e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CCND1—prostate cancer	3.25e-06	4.76e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL6—prostate cancer	3.25e-06	4.75e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PPARA—prostate cancer	3.24e-06	4.74e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CAV1—prostate cancer	3.24e-06	4.73e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CTNNB1—prostate cancer	3.22e-06	4.71e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CCND1—prostate cancer	3.18e-06	4.65e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.17e-06	4.63e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MMP9—prostate cancer	3.16e-06	4.62e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CTNNB1—prostate cancer	3.15e-06	4.61e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CDKN1A—prostate cancer	3.15e-06	4.6e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PTEN—prostate cancer	3.14e-06	4.59e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MMP9—prostate cancer	3.09e-06	4.52e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CDKN1A—prostate cancer	3.08e-06	4.5e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PTEN—prostate cancer	3.07e-06	4.49e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—AKT1—prostate cancer	3.06e-06	4.48e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CAV1—prostate cancer	3.05e-06	4.46e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—AKT1—prostate cancer	3.05e-06	4.46e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CG—prostate cancer	3.02e-06	4.42e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—AKT1—prostate cancer	3e-06	4.38e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EP300—prostate cancer	2.99e-06	4.38e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CG—prostate cancer	2.95e-06	4.31e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EP300—prostate cancer	2.93e-06	4.28e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SRC—prostate cancer	2.91e-06	4.26e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—INS—prostate cancer	2.86e-06	4.18e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SRC—prostate cancer	2.85e-06	4.17e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—VEGFA—prostate cancer	2.83e-06	4.15e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—STAT3—prostate cancer	2.81e-06	4.11e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CREBBP—prostate cancer	2.8e-06	4.1e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—INS—prostate cancer	2.79e-06	4.08e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.78e-06	4.06e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—VEGFA—prostate cancer	2.77e-06	4.06e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—STAT3—prostate cancer	2.75e-06	4.02e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CREBBP—prostate cancer	2.73e-06	4e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CD—prostate cancer	2.65e-06	3.88e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—INS—prostate cancer	2.63e-06	3.85e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MYC—prostate cancer	2.61e-06	3.82e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TGFB1—prostate cancer	2.6e-06	3.81e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CD—prostate cancer	2.59e-06	3.79e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CREBBP—prostate cancer	2.57e-06	3.77e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MYC—prostate cancer	2.55e-06	3.73e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EGFR—prostate cancer	2.55e-06	3.73e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TGFB1—prostate cancer	2.55e-06	3.72e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NOS3—prostate cancer	2.51e-06	3.67e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EGFR—prostate cancer	2.5e-06	3.65e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NOS3—prostate cancer	2.45e-06	3.58e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.44e-06	3.57e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KRAS—prostate cancer	2.41e-06	3.53e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KRAS—prostate cancer	2.36e-06	3.45e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CB—prostate cancer	2.31e-06	3.38e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NOS3—prostate cancer	2.31e-06	3.37e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTGS2—prostate cancer	2.29e-06	3.35e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CB—prostate cancer	2.26e-06	3.3e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTGS2—prostate cancer	2.24e-06	3.27e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CA—prostate cancer	2.21e-06	3.24e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CA—prostate cancer	2.17e-06	3.17e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TP53—prostate cancer	2.14e-06	3.13e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.13e-06	3.11e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTGS2—prostate cancer	2.11e-06	3.08e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TP53—prostate cancer	2.1e-06	3.07e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTEN—prostate cancer	2e-06	2.92e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL6—prostate cancer	1.96e-06	2.87e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTEN—prostate cancer	1.95e-06	2.85e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL6—prostate cancer	1.92e-06	2.81e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—EP300—prostate cancer	1.91e-06	2.79e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—EP300—prostate cancer	1.86e-06	2.72e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTEN—prostate cancer	1.84e-06	2.69e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AKT1—prostate cancer	1.81e-06	2.65e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AKT1—prostate cancer	1.77e-06	2.59e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—EP300—prostate cancer	1.75e-06	2.57e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.41e-06	2.06e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CA—prostate cancer	1.38e-06	2.01e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.3e-06	1.9e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—AKT1—prostate cancer	1.15e-06	1.69e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—AKT1—prostate cancer	1.12e-06	1.65e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—AKT1—prostate cancer	1.06e-06	1.55e-05	CbGpPWpGaD
